Sanifit touts positive PhIIb data; REGENXBIO licenses Clearside Biomedical tech
→ Rare disease biotech Sanifit — which in June, raised nearly $81 million in Spain’s largest-ever private biotech fundraise — has announced that its international …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
